On Oct 14, 2025, Zynex announced the appointment of Bret Wise to its Board of Directors and as Chair of the Audit Committee. Wise is a retired senior executive with extensive experience in the medical device industry, having served as Chair and CEO of Dentsply International from 2007 to 2016 and as Executive Chair of Dentsply Sirona from 2016 to 2017. He also held senior roles at Dentsply International from 2002 to 2006, including President, COO, and CFO, and has a background as an audit partner at KPMG.
Steven Dyson, Zynex’s CEO, said Wise would bring a great addition to our Board of Directors as the Chair of our Audit Committee as we continue to refocus the Zynex mission and vision around patient and customer success with a renewed commitment to integrity and compliance. Thomas Sandgaard, founder and Chair of the Board, added that Wise’s financial expertise adds significant value to Zynex as we continue our commitment to the highest standards of financial oversight and transparency.
Wise’s appointment strengthens the board’s governance framework and positions Zynex to navigate its ongoing strategic transformation, including the refocusing of its pain management division and the launch of its patient monitoring platform. His experience in financial management and audit oversight adds support to the company’s efforts to address liquidity challenges, refine its capital structure, and enhance investor confidence during a period of significant operational change.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.